SC
Scancell Holdings plc
SCNLF · OTC
$0.14 +0.00% (+$0.00)
1M +4.52%
Market Cap £109.5M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 23.23x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 94.95%
Net margin 260.50%
Op. margin 318.43%
Quality
4 /100
Poor ROIC 144.56%
ROA 53.15%
Asset turnover 0.20x
Debt
10 /100
High Current ratio 0.77x
Int. coverage -10.86x
Debt/Equity N/A
Stability
37 /100
Moderate Beta 0.74x
EPS volatility 108.62%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o SCNLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Phillip John L'Huillier
Employees
61
Headquarters
Oxford
Nadchodzące wydarzenia
23 PAŹ
Earnings
Upcoming earnings report
04 LUT
Earnings
Upcoming earnings report